There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Show figures in :Show figures in :
Data is unavailable
Data is unavailable
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net worth | 1156.23 | 847.23 | 752.91 | 578.56 | 424.75 | 284.06 | 253.09 | 225.94 | 196.26 | 300.28 | 287.48 | 297.11 | 299.88 |
| Fixed assets | 488.51 | 307.35 | 266.97 | 251.80 | 224.52 | 216.37 | 236.21 | 264.29 | 271.80 | 296.72 | 322.48 | 368.08 | 409.46 |
| Debt | 79.39 | 29.00 | 25.16 | 18.57 | 17.05 | 13.47 | 131.60 | 14.56 | 48.99 | 67.51 | 80.89 | 89.28 | 111.23 |
View detailed balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 32.06 | 73.37 | -91.17 | -60.24 | 50.83 | 11.02 | 17.37 | 63.41 | 40.73 | 50.07 | 50.70 | 33.52 | 33.64 |
| Investing | -321.51 | -83.30 | -46.51 | -31.68 | -70.35 | -12.46 | -13.05 | -26.93 | -13.60 | -27.30 | -31.65 | -0.80 | -2.83 |
| Financing | 299.89 | 5.20 | 143.54 | 66.33 | 47.27 | 5.49 | -0.44 | -37.77 | -23.72 | -27.26 | -19.31 | -29.14 | -29.79 |
Morepen manufactures APIs, branded and generic formulations, OTC products and Home Health devices, serving both domestic and global markets. Its manufacturing is based in Himachal Pradesh.
The company is listed on BSE and NSE. Its plants are in Baddi, Parwanoo and Masulkhana in Himachal Pradesh.
The consolidated group comprises seven subsidiaries. On a consolidated basis, APIs contribute 53.5% of revenue, followed by Diagnostics at 27.5%, Formulations at 10% and OTC at 9%.
